Cargando…

Activity-Related Dyspnoea in Chronic Pulmonary Diseases: New Mechanistic Insights

Detalles Bibliográficos
Autor principal:	O’Donnell, Denis E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Research Institute of Tuberculosis and Lung Disease 2017
Materias:	Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684729/ https://www.ncbi.nlm.nih.gov/pubmed/29158746

Ejemplares similares

“Mild” COPD: What Spirometry Conceals!
por: O’Donnell, Denis E.
Publicado: (2017)

Dyspnea in COPD: New Mechanistic Insights and Management Implications
por: O’Donnell, Denis E., et al.
Publicado: (2019)

Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing
por: O'Donnell, Denis E., et al.
Publicado: (2016)

New Concepts to Improve Health Outcomes for Patients With Chronic Obstructive Pulmonary Disease
por: Minkoff, Neil B., et al.
Publicado: (2005)

Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions
por: Hanania, Nicola A, et al.
Publicado: (2019)

Contemporary Issues in the Care of Patients With Chronic Obstructive Pulmonary Disease
por: Urbano, Frank L., et al.
Publicado: (2005)

Potential therapeutic implications of new insights into respiratory syncytial virus disease
por: Openshaw, Peter JM
Publicado: (2002)

Exertional dyspnoea in pulmonary arterial hypertension
por: Dumitrescu, Daniel, et al.
Publicado: (2017)

Dyspnoea with progressive “idiopathic” pulmonary fibrosis
por: Puri, Chahat, et al.
Publicado: (2021)

Dyspnœa in Heart Disease
por: Barrie,
Publicado: (1910)

Respiratory Consequences of Mild-to-Moderate Obesity: Impact on Exercise Performance in Health and in Chronic Obstructive Pulmonary Disease
por: O'Donnell, Denis E., et al.
Publicado: (2012)

Dyspnoea and symptom burden in mild–moderate COPD: the Canadian Cohort Obstructive Lung Disease Study
por: Cherian, Mathew, et al.
Publicado: (2021)

Adaptation and validation of the Chinese version of Dyspnoea‐12 scale in individuals with chronic obstructive pulmonary disease
por: Choi, Tiffany Ching Man, et al.
Publicado: (2021)

Exposing Pre–Chronic Obstructive Pulmonary Disease: When Physiology Matters!
por: Neder, J. Alberto, et al.
Publicado: (2021)

Psychosocial recovery after serious injury
por: O'Donnell, Meaghan
Publicado: (2014)

New Therapeutic Paradigms and Guidelines in the Management of Pulmonary Arterial Hypertension
por: Hill, Nicholas S., et al.
Publicado: (2016)

Phlebolith with dyspnoea
por: Mani, Ashwin K., et al.
Publicado: (2020)

Dyspnœa on Falling Asleep
por: Ballard, E. A.
Publicado: (1882)

Dyspnoea at Term in an Obese Mother
por: O'Dwyer, Vicky, et al.
Publicado: (2011)

Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12
por: Yorke, J, et al.
Publicado: (2010)

The Impact of the Age, Dyspnoea, and Airflow Obstruction (ADO) Index on the Medical Burden of Chronic Obstructive Pulmonary Disease (COPD)
por: Li, Chin-Ling, et al.
Publicado: (2022)

Causes and Consequences of Chronic Kidney Disease: Implications for Managed Health Care
por: Weiner, Daniel E.
Publicado: (2007)

Physical and affective components of dyspnoea are improved by pulmonary rehabilitation in COPD
por: Grosbois, Jean-Marie, et al.
Publicado: (2022)

An unusual cause of progressive dyspnoea, pulmonary nodules and pleural effusions
por: Venkatesan, Sudharsan, et al.
Publicado: (2023)

Assessment and diagnosis of chronic dyspnoea: a literature review
por: Sunjaya, Anthony Paulo, et al.
Publicado: (2022)

Acute Intermittent Dyspnœa
Publicado: (1829)

Exertional dyspnoea in obesity
por: Bernhardt, Vipa, et al.
Publicado: (2016)

Fresh Air: Dyspnœa
Publicado: (1888)

The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus Acinetobacter baumannii-calcoaceticus Complex
por: O’Donnell, John P, et al.
Publicado: (2023)

State of World Allergy Report 2008: Allergy and Chronic Respiratory Diseases
por: Pawankar, Ruby, et al.
Publicado: (2008)

Pulmonary Rehabilitation for COPD
por: Hopkinson, Nicholas
Publicado: (2017)

Managed Care to Medicare: Sharing the Burden of Chronic Kidney Disease
por: Peter, Wendy St.
Publicado: (2007)

New Therapies, Evidence, and Guidance in Hepatitis C Management: Expert Practices and Insights from an Educational Symposium at the AMCP 27th Annual Meeting Expo
por: Terrault, Norah, et al.
Publicado: (2015)

New insights into the neurofibroma tumor cells of origin
por: Li, Stephen, et al.
Publicado: (2019)

Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea
por: Cortés-Telles, Arturo, et al.
Publicado: (2021)

Pitfalls in the interpretation of pulmonary function tests in neuromuscular disease
por: Neder, José Alberto, et al.
Publicado: (2020)

Conventional, Complementary and Alternative Medicines: Mechanistic Insights into Therapeutic Landscape of Chronic Obstructive Pulmonary Disease
por: Arezina, Radivoj, et al.
Publicado: (2023)

Cardiopulmonary and Muscular Interactions: Potential Implications for Exercise (In)tolerance in Symptomatic Smokers Without Chronic Obstructive Pulmonary Disease
por: Muller, Paulo de Tarso, et al.
Publicado: (2019)

The distribution of new HIV infections by mode of exposure in Morocco
por: Mumtaz, Ghina R, et al.
Publicado: (2013)

Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease
por: Gagnon, Philippe, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3vp5ec6ouho171149ikea80gqk